Meningococcal quadrivalent tetanus toxoid conjugate vaccine (MenACWY-TT, Nimenrix™): a review of its immunogenicity, safety, co-administration, and antibody …

A Assaf-Casals, G Dbaibo - Human Vaccines & …, 2016 - Taylor & Francis
Introduction: Meningococcal disease is a major cause of morbidity and mortality worldwide
with reported epidemics and outbreaks in different parts of the world. Despite the availability …

Meningococcal quadrivalent (serogroups A, C, W135 and Y) tetanus toxoid conjugate vaccine (Nimenrix™)

JD Croxtall, S Dhillon - Drugs, 2012 - Springer
Abstract Nimenrix™(MenACWY-TT) is a quadrivalent meningococcal conjugate vaccine,
comprising the polysaccharide serogroups A, C, W135 and Y, and tetanus toxoid (TT) as …

Complications of meningococcal disease in college students

LJ Erickson, P De Wals, J McMahon… - Clinical infectious …, 2001 - academic.oup.com
A retrospective study was conducted to provide a description of the risk, complications,
fatality, and sequelae associated with invasive meningococcal disease in college students …

Bacterial agents causing meningitis during 2013–2014 in Turkey: A multi-center hospital-based prospective surveillance study

M Ceyhan, Y Ozsurekci, N Gürler… - Human vaccines & …, 2016 - Taylor & Francis
This is an observational epidemiological study to describe causes of bacterial meningitis
among persons between 1 month and 18 y of age who are hospitalized with suspected …

An expanded age range for meningococcal meningitis: molecular diagnostic evidence from population-based surveillance in Asia

SA Kim, DW Kim, BQ Dong, JS Kim, DD Anh… - BMC infectious …, 2012 - Springer
Background To understand epidemiologic patterns of meningococcal disease in Asia, we
performed a retrospective molecular analysis of cerebrospinal fluid (CSF) specimens …

[HTML][HTML] A phase 3 non-inferiority trial of locally manufactured Meningococcal ACWY vaccine 'Ingovax ACWY'among Bangladeshi adults

T Ahmed, I Tauheed, S Hoque, GS Bhuyan, R Biswas… - Vaccine, 2024 - Elsevier
Meningococcal disease is caused by Neisseria meningitidis or meningococcus. Every year
globally around 1.2 million people are affected and approximately 120,000 deaths occur …

[HTML][HTML] Can we, should we, eradicate the meningococcus?

MCJ Maiden, M Frosch - Vaccine, 2012 - Elsevier
The eradication of infectious agents is an attractive means of disease control that, to date,
has been achieved for only one human pathogen, the smallpox virus. The introduction of …

Safety and immunogenicity of two doses of a quadrivalent meningococcal polysaccharide diphtheria toxoid conjugate vaccine in indian and russian children aged 9 to …

B Javadekar, A Ghosh, RZ Kompithra, S Awasthi… - Indian Pediatrics, 2018 - Springer
Objective Evaluation of tolerability, safety and immunogenicity of a two-dose series of a
quadrivalent meningococcal polysaccharide diptheria toxoid conjugate (ACYW-D) vaccine …

[HTML][HTML] Setting priorities for development of emerging interventions against childhood pneumonia, meningitis and influenza

I Rudan, E Theodoratou, L Zgaga, H Nair… - Journal of Global …, 2012 - ncbi.nlm.nih.gov
1Centre for Population Health Sciences, The University of Edinburgh Medical School,
Edinburgh, Scotland, UK 2Nossal Institute for Global Health, University of Melbourne …

[PDF][PDF] Health related vulnerabilities and enabling institutions to facilitate responses to climate change in East Africa

AK Githeko - East Africa Science, 2021 - ajol.info
It is now accepted that climale change is having and will continue to have a direct or an
indirect impact on human health and in most cases, it will be negative. In his review the links …